BOSTON (Reuters) - Greenlight Capital ended 2020 with a 5.2% gain thanks to a dramatic fourth quarter comeback when bets on a homebuilder, jet leasing company and home security...
Keep Reading →
January 21 - Hedge Funds, Insider Trading
Shares of Oracle fell as much as 10 percent Tuesday following a third-quarter earnings report that "generally underwhelmed on most relevant metrics," according to Credit Suisse...
Keep Reading →
March 20 - Market Movers, News
It's no secret that hedge funds have been underperforming the market by quite a wide margin in the last couple of years.
Keep Reading →
February 20 - Hedge Funds, News
Shares of Arena Pharmaceuticals, Inc.
Keep Reading →
April 18 - Market Movers, News
"U.S. stocks retreated on Tuesday as a spate of tepid corporate earnings weighed on the broader market.
Keep Reading →
April 18 - Commodities, Gold, Market Movers, News, Tech
Before we get to the list of 7 over-the-counter diet pills that work without exercise, we should ask ourselves if there exists such a thing. The short answer is no.
Keep Reading →
April 12 - Lists, News
Are you interested in knowing the 7 Most Popular Diet Pills That Work Fast Without Exercise? I mean what better way to lose weight than to simply pop some pills and let the fat...
Keep Reading →
March 15 - Lists, News
The 10 best performing weight loss companies have found success in an increasingly competitive environment, one which is pitting supplement providers, medical device makers, weight...
Keep Reading →
March 9 - Lists, News
Yes, you read the title right there are at least 12 health benefits of medical marijuana according to publicly traded weed companies.
Keep Reading →
January 12 - Lists, News
Even to people who are against the legalization of marijuana, it is common knowledge now that the legal marijuana industry is growing at a rapid pace and this growth should continue...
Keep Reading →
September 12 - Hedge Funds, News
The legalization of marijuana for recreational use in some regions has not only led to the formation of small companies that grow and sell marijuana, but has also given a boost...
Keep Reading →
May 28 - Hedge Funds, News
A few years ago, most investors could not even fathom investing their money in companies dealing with illegal drugs.
Keep Reading →
March 16 - Hedge Fund Analysis, Hedge Funds, News
It's really amazing to think about how far we've come over even the past decade in the health-care arena.
Keep Reading →
September 23 - News
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) issued a press release pointing out that its marketing partner Eisai had started direct-to-consumer advertising for their obesity drug...
Keep Reading →
September 17 - News
Heart disease is the leading cause of death in the United States. In 2010, according to data from the Centers for Disease Control and Prevention, 597,689 people in the U.S.
Keep Reading →
September 16 - News
At the moment, there are many indicators investors can use to analyze stocks. Some of the most under-the-radar are hedge fund and insider trading activity.
Keep Reading →
September 12 - News
The first guy, Leland Wilson, got kicked out. Never mind that he founded the company, Samuel Colin, senior managing partner at First Manhattan, VIVUS, Inc.
Keep Reading →
September 5 - News
Stocks to Watch (Northstar Realty Finance Corp. (NYSE:NRF), Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Alpha Natural Resources, Inc.
Keep Reading →
September 3 - News
As much as I think Arena Pharmaceuticals, Inc.
Keep Reading →
September 3 - News
You really don't need both. There are enough people with rheumatoid arthritis or high cholesterol, for example, to have multiple blockbuster drugs that treat the diseases.
Keep Reading →
September 3 - News
This week, the ratings of three Pharmaceutical stocks on Portfolio Grader are down. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).
Keep Reading →
August 30 - News
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)'s Belviq, VIVUS, Inc. (NASDAQ:VVUS)'s Qsymia, and Orexigen Therapeutics, Inc. (NASDAQ:OREX)'s Contrave were rejected by the Food and...
Keep Reading →
August 29 - News
Obesity has become a central issue in the global health care agenda; both governments and their citizens are becoming increasingly more conscious about this problem, which is ...
Keep Reading →
August 28 - News
If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era lost to time.
Keep Reading →
August 28 - News
In today’s marketplace, there are dozens of gauges shareholders can use to watch stocks. A pair of the most innovative are hedge fund and insider trading movement.
Keep Reading →
August 27 - News
In the financial world, there are many methods shareholders can use to track stocks. A couple of the most innovative are hedge fund and insider trading activity.
Keep Reading →
August 27 - News
In today’s marketplace, there are a multitude of methods shareholders can use to watch stocks.
Keep Reading →
August 27 - News
While that's certainly not what Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) investors were hoping for -- at one point, after Amgen, Inc.
Keep Reading →
August 26 - News
The obesity segment of the health care industry is turning into a battleground. VIVUS, Inc.
Keep Reading →
August 23 - News
Investors in Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) saw new options become available this week, for the April 2014 expiration. ...VIVUS, Inc.
Keep Reading →
August 22 - News
Now, according to many market players, hedge funds are viewed as delayed, outdated financial tools of an era lost to time.
Keep Reading →
August 22 - News
If you were to ask many market players, hedge funds are seen as useless, outdated financial tools of a period lost to current times.
Keep Reading →
August 22 - News
The ratings of four Pharmaceutical stocks are down this week, according to the Portfolio Grader database.
Keep Reading →
August 19 - News
After my article on MannKind Corporation (NASDAQ:MNKD) earlier this week, a reader wasn't too happy about my view that the company was overvalued given the most recent phase ...
Keep Reading →
August 19 - News
Last week, the Trust for America's Health and the Robert Wood Johnson Foundation released their annual report (link opens a PDF to a 116-page report) on obesity trends in the ...
Keep Reading →
August 19 - News
We are a nation that is completely and utterly devoted to the convenience of fast food.
Keep Reading →
August 15 - News
Earlier today RFD IP Business Services ("RFD") released a new report analyzing the likely inequitable conduct challenges to VIVUS, Inc.
Keep Reading →
August 13 - News
Quite a few research papers published recently have shown that mutations in genes can control your appetite and your ability to burn calories.
Keep Reading →
August 11 - News
We are a nation that is completely and utterly devoted to the convenience of fast food.
Keep Reading →
August 11 - News
Today, let's look at Analytic Investors, founded in 1970 and based far from Wall Street, in Los Angeles.
Keep Reading →
August 7 - News
In the financial world, there are tons of indicators investors can use to watch their holdings. Some of the most under-the-radar are hedge fund and insider trading sentiment.
Keep Reading →
August 6 - News
Is Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) the right investment to pursue these days? Hedge funds are taking a bullish view.
Keep Reading →
August 6 - News
Regardless of whether you're entirely for the Patient Protection and Affordable Care Act, vehemently against it, or fall somewhere in between, it's set to become the law of the...
Keep Reading →
August 6 - News
The sales come from less than a month on the market -- the drug launched on June 11 and the quarter closed on June 30 -- and can't tell you anything about the long-term potential...
Keep Reading →
August 2 - News
Arena Pharmaceuticals, Inc.
Keep Reading →
July 31 - News
VIVUS, Inc. (NASDAQ:VVUS), which sells the obesity drug Qsymia, has appointed Anthony Zook to serve as its CEO.
Keep Reading →
July 30 - News
The two weight-loss drug approvals in 2012 were the first in more than a decade. The excitement surrounding Arena Pharmaceuticals, Inc.
Keep Reading →
July 28 - News
"As a founding CEO, over the past 22 years, Leland has secured four drug approvals, an unheard-of achievement for a small pharmaceutical company. He has taken VIVUS, Inc.
Keep Reading →
July 19 - News
